医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku

2022年08月12日 PM01:30
このエントリーをはてなブックマークに追加


 

TOKYO

On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning the effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair, as well as its effects for promotion of hair growth in mice. Agaricus blazei mushroom, KA21 strain is being sold as a supplement within Japan, mainly to clinics providing hair growth treatment and other medical institutions.

About Agaricus blazei, brasiliensis, subrufescens

Agaricus blazei (also known as A. brasiliensis, A. subrufescens) is a medicinal mushroom. It is popular primarily in Asian countries (particularly Japan) as an ingredient of immune booster used in complementary and alternative medicine (CAM). Characteristics of Agaricus blazei such as safety and effectiveness vary significantly depending on the strain, cultivation method, and production region.

Agaricus KA21 (Common name: King Agaricus)

Agaricus KA21 is Agaricus blazei KA21 strain cultivated outdoors in Brazil under direct sunlight. Compared to regular Agaricus blazei cultivated in a dark greenhouse, Agaricus KA21 is large in size, contains an abundance of major ingredients such as beta-glucan and vitamin D, and offers an antioxidant activity level over five times greater. Outdoor cultivation is extremely difficult with small yield, therefore Agaricus KA21 is a rare commodity. Toei Shinyaku is the sole company in the world that sells it.

Toei Shinyaku Co.,Ltd.

Established in 1973, Toei Shinyaku is a Japanese manufacturer that specializes in R&D activities, as well as the manufacture and sale of Agaricus KA21. Toei Shinyaku has conducted research on Agaricus KA21 for over 25 years and presented 32 international papers on its findings; making it the company with the greatest research results out of all Japanese Agaricus blazei manufacturers. Toei Shinyaku discloses evidence supporting its product, Agaricus KA21, on its official homepage. Details include the safety of human clinical trials of Agaricus KA21, ability to strengthen the immune system, alleviate fatigue, improve hair loss and gray hair, and prevent fungal infection. Data also includes the effect of Agaricus KA21 found through trials on mice; such as reducing side effects of anticancer drugs, hair growth benefits, and enhanced wound healing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220807005052/en/

CONTACT

Toei Shinyaku Co.,Ltd.

Akitomo Motoi

info@toeishinyaku.jp

Cross-Border EC website: www.toeishinyaku.jp

For business inquiry including wholesales and OEM: www.agaricus.co.jp

Main Products: Akkerman Slim etc.

同じカテゴリーの記事 

  • Shaperon to Conduct Strategic Partnering and Institutional Investor Meetings at the 10th Annual BFC Healthcare Business Development & Investment Conference in Shanghai
  • Makana™ Issued Patent in South Korea for Its Genetically-Modified TKO Pig for Use in Xenotransplantation
  • Fast Fitness Japan Obtains Master Franchisee Rights for Anytime Fitness in Germany
  • ATLATL Scientific and Miltenyi Biotec: A Five-Year Partnership Driving Biotech Innovation in Singapore and Beyond
  • 世界経済フォーラム(WEF)特別会合リヤドが閉幕平和と繁栄への明確で不可逆的な道をグローバルな最優先課題とすることを呼びかける